# Tedor Pharma, Inc. – FDA Inspection, Jun 5, 2025

Source: https://www.keypedia.com/records/fda_inspections/tedor-pharma-inc/d130b166-4fa4-417a-9823-05222a5913f9
Source feed: FDA_Inspections

> FDA inspection 1271887 of Tedor Pharma, Inc., June 05, 2025. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1271887
- Company Name: Tedor Pharma, Inc.
- Inspection Date: 2025-06-05
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New England District Office
- Citation Count: 2

## Related Documents

- [FDA Inspection 1077786 - 2019-01-31](https://www.keypedia.com/records/fda_inspections/tedor-pharma-inc/9b5aa688-b7e6-4e1c-8397-a3e9cf008050)
- [FDA Inspection 1010372 - 2017-04-20](https://www.keypedia.com/records/fda_inspections/tedor-pharma-inc/6d50ae4a-31d4-4a0a-a156-4831edc01911)
- FDA Inspection 853221 - 2013-10-29
- FDA Inspection 743987 - 2011-09-09

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/lori-m-newman/a0e448e4-11ba-4095-b879-feabb8750b3f)

Company: https://www.keypedia.com/companies/tedor-pharma-inc/a9fa17c4-23c1-4bcf-ad03-bb9635bb063d

Office: https://www.keypedia.com/offices/new-england-district-office/aa458072-2f1d-4231-89f5-21ba7a3b7144
